The operative treatment of full thickness cartilage defects in the knee joint with autologous chondrocyte transplantation

Citation
C. Erggelet et al., The operative treatment of full thickness cartilage defects in the knee joint with autologous chondrocyte transplantation, SAUDI MED J, 21(8), 2000, pp. 715-721
Citations number
21
Categorie Soggetti
General & Internal Medicine
Journal title
SAUDI MEDICAL JOURNAL
ISSN journal
03795284 → ACNP
Volume
21
Issue
8
Year of publication
2000
Pages
715 - 721
Database
ISI
SICI code
0379-5284(200008)21:8<715:TOTOFT>2.0.ZU;2-O
Abstract
Objectives: The high clinical and socio-economical impact of cartilage defe cts and chondral degeneration is well-known. After trauma or without a know n etiology, often young patients suffer from pain and a loss of function le ading into a decrease of physical activity and, more severe, into long term disability and unemployment, The clinical use of autologous chondrocyte tr ansplantation was introduced in 1994 reporting the data of a pilot study. T he objective of this study is to evaluate the efficacy of this method of su rgery. Methods: Autologous chondrocyte transplantation has been established in our department since 1995 for the treatment of large, full thickness cartilage defects which can be completely covered with hyaline-like cartilage withou t harming the subchondral bone plate. Our first patients (n=24) all showed Grade IV lesions and an average defect size of 6.27 cm(2). All but 4 of the patients had at least 1 cartilage defect related operation on the knee. Results: The patients and the clinicians rating indicated an increase of a modified Cincinnati Knee score from 3.6 point pre-operation to 6.9 points a fter 6 months and 8.1 points at 12 months on a scale from 1 (bad) to 10 (ex cellent). These results support the data of an international multicenter st udy with almost 2000 patients. The 5 year results described by the originat e authors are good to excellent in 85%-95% with an adverse event rate of 5% . Conclusion: Autologous chondrocyte transplantation has to be considered a s afe and effective method for the treatment of large full thickness cartilag e defects. Alternative treatments are symptomatical: drilling, abrasion, la vage, chondroplasty, or osteotomies. The short term results are promising b ut a lot of patients have to be treated for osteoarthritis as a consequence of failure with total joint arthroplasty. Osteochondral transplantations h ave the disadvantage of limited harvesting sites and the impairment of the subchondral bone plate.